APA

Liu L., Zeng W., Wortinger M. A., Yan S. B., Cornwell P., Peek V. L., Stephens J. R., Tetreault J. W., Xia J., Manro J. R., Credille K. M., Ballard D. W., Brown-Augsburger P., Wacheck V., Chow C., Huang L., Wang Y., Denning I., Davies J., Tang Y., Vaillancourt P. & Lu J. (20150728). LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

Liu Ling, Zeng Wei, Wortinger Mark A, Yan S Betty, Cornwell Paul, Peek Victoria L, Stephens Jennifer R, Tetreault Jonathan W, Xia Jinqi, Manro Jason R, Credille Kelly M, Ballard Darryl W, Brown-Augsburger Patricia, Wacheck Volker, Chow Chi-Kin, Huang Lihua, Wang Yong, Denning Irene, Davies Julian, Tang Ying, Vaillancourt Peter and Lu Jirong. 20150728. LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

Liu L., Zeng W., Wortinger M. A., Yan S. B., Cornwell P., Peek V. L., Stephens J. R., Tetreault J. W., Xia J., Manro J. R., Credille K. M., Ballard D. W., Brown-Augsburger P., Wacheck V., Chow C., Huang L., Wang Y., Denning I., Davies J., Tang Y., Vaillancourt P. and Lu J. (20150728). LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

Liu Ling, Zeng Wei, Wortinger Mark A, Yan S Betty, Cornwell Paul, Peek Victoria L, Stephens Jennifer R, Tetreault Jonathan W, Xia Jinqi, Manro Jason R, Credille Kelly M, Ballard Darryl W, Brown-Augsburger Patricia, Wacheck Volker, Chow Chi-Kin, Huang Lihua, Wang Yong, Denning Irene, Davies Julian, Tang Ying, Vaillancourt Peter and Lu Jirong. LY2875358, a neutralizing and internalizing anti-MET bivalent antibody, inhibits HGF-dependent and HGF-independent MET activation and tumor growth. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20150728.